The involvement of PDK2 in hepatic steatosis and cancer, via the regulation of glucose metabolism pathways, has been reported, and the upregulation of PDK2 expression in tumor cells is usually considered an important driver of metabolic rewiring (15, 50). The gene discussed is PDK2; the disease is fatty liver disease.